Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115110112 | 11511011 | 2 | F | 20060711 | 20160713 | 20150915 | 20160719 | EXP | US-TAKEDA-TPA2013A06203 | TAKEDA | 0.00 | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115110112 | 11511011 | 1 | PS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 2 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 3 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 4 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 5 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 6 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 7 | SS | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | Oral | 45 MG, UNK | 21073 | 45 | MG | TABLET | |||||||
| 115110112 | 11511011 | 8 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 500 MG, UNK | U | 0 | 500 | MG | ||||||||
| 115110112 | 11511011 | 9 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MG, UNK | U | 0 | 1000 | MG | ||||||||
| 115110112 | 11511011 | 10 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 100 MG, UNK | U | 0 | 100 | MG | ||||||||
| 115110112 | 11511011 | 11 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 115110112 | 11511011 | 12 | C | LANTUS | INSULIN GLARGINE | 1 | UNK | U | 0 | ||||||||||
| 115110112 | 11511011 | 13 | C | LEVEMIR | INSULIN DETEMIR | 1 | UNK | U | 0 | ||||||||||
| 115110112 | 11511011 | 14 | C | GLUCOTROL | GLIPIZIDE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115110112 | 11511011 | 1 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115110112 | 11511011 | DE |
| 115110112 | 11511011 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115110112 | 11511011 | Bladder transitional cell carcinoma | |
| 115110112 | 11511011 | Death |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115110112 | 11511011 | 1 | 20040623 | 20041105 | 0 | |
| 115110112 | 11511011 | 2 | 20041201 | 20050721 | 0 | |
| 115110112 | 11511011 | 3 | 20050722 | 20051127 | 0 | |
| 115110112 | 11511011 | 4 | 20051208 | 20061127 | 0 | |
| 115110112 | 11511011 | 5 | 20061226 | 20070302 | 0 | |
| 115110112 | 11511011 | 6 | 20080305 | 20090801 | 0 | |
| 115110112 | 11511011 | 7 | 20091211 | 201109 | 0 | |
| 115110112 | 11511011 | 8 | 2004 | 2006 | 0 | |
| 115110112 | 11511011 | 9 | 2006 | 2007 | 0 | |
| 115110112 | 11511011 | 10 | 2008 | 2011 | 0 | |
| 115110112 | 11511011 | 12 | 2008 | 2011 | 0 |